Will Sargent, formerly head of orthopaedics business development at Auxilium Pharmaceuticals, has joined Nabriva Therapeutics AG as head of commercial strategy and investor relations. Mr Sargent will be located at the company’s US headquarters in King of Prussia, Pennsylvania. Nabriva, which is developing anti-infectives, is based in Vienna, Austria.
Mr Sargent held executive positions in marketing, sales and investor relations at Auxilium, which was acquired by Endo International in 2015. Before this, he was a biotechnology equities analyst at Bank of America. He holds a BA in biology from Johns Hopkins University and an MBA from the University of Washington, both in the US.
Nabriva announced the appointment on 14 October 2015.
Copyright 2015 Evernow Publishing Ltd